Trial
NCT06014385
PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Janssen Scientific Affairs, LLC
Condition
Muscarinic Receptor Occupancy
Intervention
Scopolamine
Why stopped
lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-11